Summary
UnitedHealth (UNH) has earned a bullish stock rating from GAR Capital as a deeply undervalued blue-chip opportunity. With strong seasonality, a growing dividend, and a 44% upside target, we see long-term potential building into 2026.
Market Movers
No market movers this week..
📚 Deep Dive 📚
📈 Stock Spotlight: UnitedHealth Group (UNH) — A Value Play with Big Upside By GAR Capital
Market Intel Series | July 2025
💡 Traders, let’s talk about the next setup that has my attention: UnitedHealth Group (UNH).
👉 Current price: ~$312
👉 Key support: 300 (major level I’m watching — hold this and we’re good)
👉 12-month target: 450
That’s a clean +44% upside from here if we play this right.
📊 Why I Like It
✅ Cheap valuation — UNH is trading at just 12.9x earnings, a major discount for a company of this caliber.
✅ Dividend strength — 2.8% yield while we wait, and they’ve raised that dividend for 15 consecutive years.
✅ Solid business — Profitable, reliable, and positioned well in the healthcare space.
UNH is down -35% over the last 12 months, and that’s exactly the kind of dislocation that presents opportunity.
📈 Seasonality Winds at Our Back
July seasonality on UNH is strong — just look at the chart below. Historically, we see powerful moves from mid-year through December. This is the kind of tailwind I like when I’m eyeing long-term swing trades.
📊 Chart source: EquityClock
🚀 The Plan
We’re long with eyes on 300 support. Any break of that, and we reassess. As long as we hold, I see a path to 450 over the next 12 months. We’ll collect that 2.8% yield as we go.
💥 Bottom Line
UNH gives us value, income, and a clean setup for a multi-month move higher. Stay tuned — more updates coming as this trade develops.